Gastrointestinal (GI)

Slides:



Advertisements
Similar presentations
SOUTH NORFOLK CLINICAL COMMISSIONING GROUP Stakeholder Event 20 th November 2013 Dr Jon Bryson, Chair - South Norfolk CCG Ann Donkin, Chief Officer.
Advertisements

Interpreting the Commissioning for Value Packs
Adding local value to Commissioning for Value
4th Annual Investor Conference May 16, 2001 HEALTH PLANS DIVISION Panel Discussion: Contributing Value to Cost of Care.
Shared Decision Making – No decision about me, without me Kim Teasdale and Sam Hood Commissioning Managers South Tyneside and Gateshead CCGs
Managing Medicines Use by PBC Groups in West Hertfordshire Dr Alison Davies.
Commissioning for Value Tool Bryn Shorney Analytical Services.
NHS Rushcliffe Clinical Commissioning Group (CCG).
North Somerset Clinical Commissioning Group Priorities Dr Mary Backhouse Chief Clinical Officer.
TBS Seminar on Essential Medicines and Health Products Geneva, 29 October 2013 Matthew Jowett, PhD Senior Health Financing Specialist Dept. Health Systems.
Challenges Objectives CCG Led Initiatives Vision ‘How’ Outcome Aspirations Better integrated health and social care Improve the health and wellbeing of.
CLINICAL STRATEGY REVIEW. Why?  Our Orkney Our Health - outdated  Redesign progress  Orkney Health & Care  Outline Business Case  New technology,
NHSScotland Procurement Review The Procurement Journey November 2014.
MEDICINES OPTIMISATION IN DIABETES Yvonne Parker Medicines Optimisation Pharmacist Stoke-on-Trent CCG.
Diseases of Childhood Expert Working Group 1 st March 2012.
National Diabetes Information Service: Masterclass Claire Martin: Diabetes Project Manager: East Kent 12 th September 2013.
Am J Gastroenterol 2012; 107:405–410 Fellow : Kim Jung Wook.
Feedback from Stakeholder Engagement Event 6 th July 2016 Neonatal Service Review.
Systematic QIPP Development Adoption of NHS Right Care
Corporate Performance Report December 2012
Adult Hearing Services (Audiology)
QIPP, Turnaround & Right Care
Operational Plan 2017/18 and 2018/19
Commissioning for Value Focus Pack
Clinical Medical Assisting
Right Care Deep Dives NEW Devon CCG Blood Disorders.
Right Care Deep Dives NEW Devon CCG Infectious Diseases.
Respiratory Services Right Care Optimisation Workshop
Right Care Deep Dives NEW Devon CCG Poisoning.
CVD Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Respiratory Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Maternity and Neonatal, Skin, Vision and Hearing Deep Dive Workshop Understanding “what to change” using the NHS Right Care methodology Part of the NEW.
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
THE APPROPRIATENESS OF PPI PRESCRIPTION IN A GENERAL MEDICAL COHORT
Lead for the quantitative evaluation
MSK Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Cancer Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
QIPP Projects Update Newbury and District CCG April 2016
PSO – Paper Switch Off Project
Supplementary analysis
J.Livie1, E.Goodall1, M.Wilson2,C.Payne2 Department of Surgery2
The evolution and revolution of Primary Medical Care
Dr James Carlton, Medical Adviser
Annual General Meeting
Challenges Vision ‘How’ Objectives Outcome Aspirations
15/16 Achievements and ambition for 16/17
Frimley Health and Care Integrated Care System
Repeat Prescribing Ensure at least one member of staff has received Practice Medicines Co-ordinator training (or equivalent) Ensure repeat requests are.
Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study  Louise Wang,
Neurological Services Deep Dive Workshop Understanding “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
ESOPS East Sussex Outpatient Services Ltd an independent provider within the NHS family January 2018 ©ESOPS 2008.
Increase in Activity – Referrals (HUH)
Stockport Together Outpatients Business Case Clinical Engagement Event
Finance Update October 2018/19.
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Berkshire West ICS Strategic Priorities
Example:- Emergency GI Bleeds
Pharmacy practice and the healthcare system Ola Ali Nassr
Benefits Approach ePrescribing Masterclass Webex Kathy Wallis, ePrescribing Domain expert 11 February 2015.
Operational Plan 2017/18 and 2018/19
Care Closer to Home Working with the voluntary sector
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
Pharmacy – Fully Insured versus Self Funding
Transforming Clinical Services
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
Clair Huckerby Consultant Pharmacist
Example:- Emergency GI Bleeds
Reducing the Days Children Spend in the Hospital
Herts and Essex Project Joint PPG Meeting
GI Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Presentation transcript:

Gastrointestinal (GI) Right Care Optimisation Workshop Tuesday 10 November 2015

GI – Elective Opportunity

GI - Prescribing Opportunity

Deep dive The GI deep dive identified two projects: Review of GI elective / day case activity Reduction of GI primary care prescribing costs

Review of GI elective / day case activity To reduce costs and variation and improve patient experience within GI planned care. Providing financial benefit of around £1,820,000. Scope includes: Hepatobiliary spend Lower GI Other GI.

From deep dive data pack

Discussion questions How can we reduce hepatobiliary outpatient spend? What can be done to reduce variation in referral rates for cholecystectomy and numbers of procedures? What can be done to review coding for HRGs related to inflammatory bowel disease in the lower gastro-intestinal subcategory? And reduce variation in referral rates? How should we improve the value of colonoscopies by reducing the ratio of diagnostic to therapeutic colonoscopies?

Discussion questions continued Would increasing endoscopies, including a biopsy, from 45% to closer to the 65% for the comparator CCGs have any clinical or financial benefit? Why are there a higher proportion of admissions that have complications and comorbidities recorded for cholecystectomies than elsewhere? What can be done? How can we reduce admissions with a zero length of stay where there are no complications?

Reduction of GI primary care prescribing costs To reduce primary care prescribing costs by a total of between £292,000 and £1,880,000. Early implementation will lead to a proportion of savings within 2015/16. Scope highlighted areas for review: Stoma prescribing Upper GI Hepatobiliary Lower GI

From Deep Dive Data pack

Mapping Stoma products cost per 1,000 patients

PrescQIPP Subscribers Stoma cost per 1,000 patients top 50%; Apr - Aug15

PrescQIPP Subscribers Stoma cost per 1,000 patients btm 50%; Apr - Aug15

Stoma: current work streams North and East Stoma Formulary - chapter 19 on formulary website (accessory products) Review of North and East Stoma Formulary Creation of South and West Stoma Formulary Scoping of CCGs - Portsmouth, Oxford, Herts Valley, North East Essex, Nene Review of guidelines for issuing prescriptions for stoma appliances.

Upper GI prescribing Below national median Variance driven by agents for dyspepsia Below median for antisecretory agents Drive to reduce PPI use as part of C. Diff strategy.

Hepatobiliary prescribing Variance driven by immunosuppressants Includes 20% of azathioprine and 25% of mycophenolate prescribing These drugs have different supply mechanisms; may be prescribed in secondary care in some CCGs. Therefore primary care prescribing may not be an appropriate comparison.

Lower GI prescribing Variance driven by: Laxatives High volume, low acquisition cost Antispasmodics Work already underway on switches Treatment for acute diarrhoea Includes 5% codeine Main driver is generic loperamide. Merbentyl – dicycloverine –phase 2 Mebeverine – colofac – pase 1

For consideration: Is a re-procurement project around stoma prescribing, to negotiate a contract with a single supplier to minimise costs and reduce device variance a viable option? What is the best way forward? How can we reduce prescribing volume and costs for primary care prescribing?

Thank you